Michael Rehli

Michael Rehli

Auto-generated profile, based on publicly available information

Michael Rehli

University Hospital Regensburg

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2014 in Nature
Verified
Journal Article
Closed access
PDF file
TCThe FANTOM Consortium
The FANTOM Consortium
RARobin Andersson
Robin Andersson
CGClaudia Gebhard
Claudia Gebhard
IMIrene Miguel-Escalada
Irene Miguel-Escalada
IHIlka Hoof
Ilka Hoof
ASAlbin Sandelin
Albin Sandelin

5 January 2015 in Genome Biology
Verified
Journal Article
Open access
PDF file
MLMarina Lizio
Marina Lizio
JHJayson Harshbarger
Jayson Harshbarger
HSHisashi Shimoji
Hisashi Shimoji
JSJessica Severin
Jessica Severin
TKTakeya Kasukawa
Takeya Kasukawa
TCthe FANTOM consortium
the FANTOM consortium
The FANTOM5 project investigates transcription initiation activities in more than 1,000 human and mouse primary cells, cell lines and tissues using CAGE. Based on manual curation of sample information and development of an ontology for sample classification, we assemble the resulting data into a centralized data resource (http://fantom.gsc.riken.jp/5/). This resource contains web-based tools and data-access points for the research community to search and extract data related to samples, genes, promoter activities, transcription factors and enhancers across the FANTOM5 atlas.

1 November 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MRMichael Rehli
Michael Rehli
HNHans-Helmut Niller
Hans-Helmut Niller
CAChristoph Ammon
Christoph Ammon
SLSabine Langmann
Sabine Langmann
LSLucia Schwarzfischer
Lucia Schwarzfischer
SKStefan W Krause
Stefan W Krause
The protein product of the CHI3L1 gene, human cartilage 39-kDa glycoprotein (HC-gp39), is a tissue-restricted, chitin-binding lectin and member of glycosyl hydrolase family 18. In contrast to many other monocyte/macrophage markers, its expression is absent in monocytes and strongly induced during late stages of human macrophage differentiation. To gain insights into the molecular mechanisms underlying its cell typerestricted and maturation-associated expression in macrophages, we initiated a detailed study of the proximal HC-gp39 promoter. Deletion analysis of reporter constructs in macrophage-like THP-1 cells localized a region directing high levels of macrophage-specific reporter gene expression to ∼300 bp adjacent to the major transcriptional start site. The promoter sequence contained consensus binding sites for several known factors, and specific binding of nuclear PU.1, Sp1, Sp3, USF, AML-1, and C/EBP proteins was detectable in gel shift assays. In vivo footprinting assays with dimethyl sulfate demonstrate that the protection of corresponding sequences was enhanced in macrophages compared with monocytes. Mutational analysis of transcription factor binding sites indicated a predominant role for a single Sp1 binding site in regulating HC-gp39 promoter activity. In addition, gel shift assays using nuclear extracts of monocytes and macrophages demonstrated that the binding of nuclear Sp1, but not Sp3, markedly increases during macrophage differentiation. Our results further highlight the important role of Sp1 in macrophage gene regulation.

3 June 2009 in Genome Research
Verified
Journal Article
Closed access
PDF file
CSChristian Schmidl
Christian Schmidl
MKMaja Klug
Maja Klug
TBTina J. Boeld
Tina J. Boeld
RAReinhard Andreesen
Reinhard Andreesen
PHPetra Hoffmann
Petra Hoffmann
MRMichael Rehli
Michael Rehli
DNA methylation participates in establishing and maintaining chromatin structures and regulates gene transcription during mammalian development and cellular differentiation. With few exceptions, research thus far has focused on gene promoters, and little is known about the extent, functional relevance, and regulation of cell type-specific DNA methylation at promoter-distal sites. Here, we present a comprehensive analysis of differential DNA methylation in human conventional CD4+T cells (Tconv) and CD4+CD25+regulatory T cells (Treg), cell types whose differentiation and function are known to be controlled by epigenetic mechanisms. Using a novel approach that is based on the separation of a genome into methylated and unmethylated fractions, we examined the extent of lineage-specific DNA methylation across whole gene loci. More than 100 differentially methylated regions (DMRs) were identified that are present mainly in cell type-specific genes (e.g.,FOXP3,IL2RA,CTLA4,CD40LG, andIFNG) and show differential patterns of histone H3 lysine 4 methylation. Interestingly, the majority of DMRs were located at promoter-distal sites, and many of these areas harbor DNA methylation-dependent enhancer activity in reporter gene assays. Thus, our study provides a comprehensive, locus-wide analysis of lineage-specific methylation patterns in Treg and Tconv cells, links cell type-specific DNA methylation with histone methylation and regulatory function, and identifies a number of cell type-specific, CpG methylation-sensitive enhancers in immunologically relevant genes.

1 March 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MRMichael Rehli
Michael Rehli
APAlexander Poltorak
Alexander Poltorak
LSLucia Schwarzfischer
Lucia Schwarzfischer
SKStefan W Krause
Stefan W Krause
RAReinhard Andreesen
Reinhard Andreesen
BBBruce Beutler
Bruce Beutler
The protein product of the Toll-like receptor (TLR) 4 gene has been implicated in the signal transduction events induced by lipopolysaccharide (LPS). In mice, destructive mutations ofTlr4 impede the normal response to LPS and cause a high susceptibility to Gram-negative infection. Expression of TLR4 mRNA in humans is restricted to a small number of cell types, including LPS-responsive myeloid cells, B-cells, and endothelial cells. To investigate the molecular basis for TLR4 expression in cells of myeloid origin, we cloned the human TLR4 gene and analyzed its putative 5′-proximal promoter. In transient transfections a region of only 75 base pairs upstream of the major transcription initiation site was sufficient to induce maximal luciferase activity in THP-1 cells. The sequence of this region is similar in human and mouse TLR4 genes and lacks a TATA box, typical Sp1-sites or CCAAT box sequences. Instead, it contains consensus-binding sites for Ets family transcription factors, octamer-binding factors, and a composite interferon response factor/Ets motif. The activity of the promoter in macrophages was strictly dependent on the integrity of both half sites of the composite interferon response factor/Ets motif, which was constitutively bound by the myeloid and B-cell-specific transcription factor PU.1 and interferon consensus sequence-binding protein. These results indicate that the two tissue-restricted transcription factors PU.1 and interferon consensus sequence-binding protein participate in the basal regulation of human TLR4 in myeloid cells. Cloning of the human TLR4 gene provides a basis for further investigation of the possible impact of genetic variations on the susceptibility to infection and sepsis.

24 April 2014 in Blood
Verified
Journal Article
Open access
PDF file
CSChristian Schmidl
Christian Schmidl
KRKathrin Renner
Kathrin Renner
KPKatrin Peter
Katrin Peter
RERuediger Eder
Ruediger Eder
TLTimo Lassmann
Timo Lassmann
MRMichael Rehli
Michael Rehli
Human blood monocytes comprise at least 3 subpopulations that differ in phenotype and function. Here, we present the first in-depth regulome analysis of human classical (CD14++CD16−), intermediate (CD14+CD16+), and nonclassical (CD14dimCD16+) monocytes. Cap analysis of gene expression adapted to Helicos single-molecule sequencing was used to map transcription start sites throughout the genome in all 3 subsets. In addition, global maps of H3K4me1 and H3K27ac deposition were generated for classical and nonclassical monocytes defining enhanceosomes of the 2 major subsets. We identified differential regulatory elements (including promoters and putative enhancers) that were associated with subset-specific motif signatures corresponding to different transcription factor activities and exemplarily validated novel downstream enhancer elements at the CD14 locus. In addition to known subset-specific features, pathway analysis revealed marked differences in metabolic gene signatures. Whereas classical monocytes expressed higher levels of genes involved in carbohydrate metabolism, priming them for anaerobic energy production, nonclassical monocytes expressed higher levels of oxidative pathway components and showed a higher mitochondrial routine activity. Our findings describe promoter/enhancer landscapes and provide novel insights into the specific biology of human monocyte subsets. Key Points In-depth regulome analysis of human monocyte subsets, including transcription and enhancer profiling. Description of metabolomic differences in human monocyte subsets.